[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
May NaN, 2002

ICDs Are Cost-effective

Author Affiliations

Not Available

Not Available

JAMA. 2002;287(20):2645. doi:10.1001/jama.287.20.2645-JQU20005-3-1

Implantable cardioverter defibrillators (ICDs) are moderately cost-effective for preventing sudden cardiac death, report researchers in the April 15 issue of Circulation: Journal of the American Heart Association.

In the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, the devices were shown to be superior to therapy with antiarrhythmic medications for reducing all causes of death in survivors of ventricular fibrillation, said Greg Larsen, MD, lead author and staff cardiologist at the Portland Veterans Affairs Medical Center in Oregon.

First Page Preview View Large
First page PDF preview
First page PDF preview